← Product Code [GEI](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI) · K110695 # BIPOLAR HF DEVICE (K110695) _Aesculap, Inc. · GEI · Jun 28, 2011 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI/K110695 ## Device Facts - **Applicant:** Aesculap, Inc. - **Product Code:** [GEI](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI.md) - **Decision Date:** Jun 28, 2011 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4400 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Indications for Use Aesculap's Bipolar Coagulator (GN160) is intended for use in surgery to generate electrical power for bipolar instruments. Bipolar coagulators are used in neurosurgery, ENT surgery, urology, laparoscopy, and plastic surgery. ## Device Story Non-sterile, reusable electrosurgical generator; generates high-frequency electrical current for coagulation via bipolar instruments (e.g., forceps). Device features bipolar outlet; universal power adapter (100-240V); metallic/thermoplastic enclosure. Operated via foot control. Software-based program manages electrical output. Used in clinical surgical settings (neurosurgery, ENT, urology, laparoscopy, plastic surgery) by surgeons. Provides controlled electrical power to instruments to achieve tissue coagulation, aiding surgical hemostasis. ## Clinical Evidence Bench testing only. No clinical testing performed. Device conforms to IEC 60601-1, IEC 60601-2-2, IEC 60601-1-2, and IEC 62304 standards. ## Technological Characteristics Reusable electrosurgical generator; metallic and thermoplastic enclosure; bipolar outlet; universal power adapter (100-240V). Energy source: high-frequency electrical current. Software-controlled. Conforms to IEC 60601-1, 60601-2-2, 60601-1-2, and IEC 62304. ## Regulatory Identification An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current. ## Predicate Devices - Aesculap Bipolar Coagulator ([K952524](/device/K952524.md)) - Wolf Model 2352 ([K945914](/device/K945914.md)) - Valleylabs Force FZ ([K953195](/device/K953195.md)) - Valleylabs Forcetriad ([K102913](/device/K102913.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K110695 P4 ## B. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS JUN 2 8 2011 lof 2 Aesculap Bipolar High Frequency (HF) Device June 13, 2011 Aesculap®, Inc. COMPANY: 3773 Corporate Parkway Center Valley, PA 18034 Establishment Registration Number: 2916714 CONTACT Lisa M. Boyle, Sr. RA Specialist 800-258-1946 x 5274 (phone) 610-791-6882 (fax) lisa.bovle@aesculap.com TRADE NAME: Aesculap Bipolar High Frequency (HF) Device COMMON NAME: Bipolar HF Electrosurgical Unit CLASS. NAME: Electrosurgical, Cutting & Coagulation & Accessories (GEI) REG. NUMBER: 878.4400 (Class II) ## SUBSTANTIAL EQUIVALENCE The Aesculap Bipolar HF Device as described in this premarket notification is substantially equivalent to the following predicate devices: Aesculap Bipolar Coagulator (K952524) . - Wolf Model 2352 {K945914} . - Vallevlabs Force FZ (K953195) . - . Vallevlabs Forcetriad (K102913) #### DEVICE DESCRIPTION Aesculap's Bipolar HF Device is a non-sterile, reusable electrosurgical generator capable of generating high frequency electrical current, driven through a software based program, for coaqulation with existing Aesculap bioolar instruments (e.g. forceps). It is equipped with a bipolar outlet. The device is fitted with a universal power adapter for mains voltages 100-120V and 220-240V. All software and electrical components are housed within a combination metallic and thermoplastic enclosure. A bipolar cord connects the instruments to the unit. The unit is activated by means of a foot control. #### INDICATIONS FOR USE Aesculab's Bipolar Coagulator (GN160) is intended for use in surgery to generate electrical power for bipolar instruments. Bipolar coagulators are use in Neurosurgery, ENT surgery, urology, laparoscopy and plastic surgery. ## TECHNOLOGICAL CHARACTERISTICS(compared to Predicate(s)) The Aesculap Bipolar HF Device described in this premarket notification share similar features and functions such as intended use, labeling, and basic operating principles to the following predicate devices: Aesculap Bipolar Coaqulator (K952524), Wolf Model 2352 (K945914), Valleylabs Force FZ (K953195), and the Valleylabs Forcetriad (K102913). {1}------------------------------------------------ ## K110695 Pg 2 of 2 Testing of the subject device was found to be similar in performance to the previously cleared device with similar indications. ## PERFORMANCE DATA No performance standards have been promulgated under Section 514 of the Food. Drug and Cosmetic Act for these devices. The Aesculap Bipolar HF Device conforms to the following IEC standards: - IEC 60601-1: Medical electrical equipment - Part 1: General requirement for safety, ● - IEC 60601-2-2: Medical electrical equipment - Part 2: Particular requirements for the safety . of high frequency surgical equipment, - . IEC 60601-1-2: Medical electrical equipment - Part 1: General requirements for safety - 2. Collateral Standard: Electromagnetic compatibility EMC Requirements and Tests. - IEC 62304: Medical device software Software life cycle process . Testing results demonstrate that the Aesculap Bipolar HF Device is safe and effective. No clinical testing was performed. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with three lines forming its body and wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Aesculap, Inc. % Ms. Lisa M. Boyle Sr. Regulatory Affairs Specialist 3773 Corporate Parkway Center Valley, Pennsylvania 18034 JUN 28 2011 Re: K110695 Trade/Device Name: Bipolar HF Device Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: June 15, 2011 Received: June 16, 2011 Dear Ms. Boyle: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act {3}------------------------------------------------ Page 2 - Ms. Lisa M. Boyle or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm11118800.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR, Part. 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Special 510(k) Premarket Notification Aesculap Bipolar HF Device (GN160) Page 1 of 1 # A. INDICATIONS FOR USE STATEMENT KII 0695 510(k) Number:________________________________________________________________________________________________________________________________________________________________ ## Device Name: Aesculap Bipolar HF Device # Indications for Use: Aesculap's Bipolar Coagulator (GN160) is intended for use in surgery to generate electrical power for bipolar instruments. Bipolar coagulators are used in neurosurgery, ENT surgery, urology, laparoscopy, and plastic surgery. | Prescription Use | X | and/or Over-the-Counter Use | | |-----------------------------|---|-----------------------------|--| | (Part 21 CFR 801 Subpart D) | | (21 CFR 801 Subpart C) | | (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number K110695 --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI/K110695](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI/K110695) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com